Health Insurance Marketplace — Open Enrollment November 1, 2015 – January 31, 2016 —

Campuses: Home button

Clinical Trials Currently Open

Below is a list of clinical trials currently offered at the Cancer Institute of Florida Hospital Memorial Medical Center.
For any questions or to learn if you qualify for a trial, please contact our clinical trial research coordinators at (386) 231-4023 or (386) 231-4026.


Breast Cancer Studies

A Breast Cancer Information Registry for Participants With Breast Cancer or Characteristics of Hereditary Breast Cancer (BCCR)

Lung Cancer Studies

No trials are currently running.  Please check back for updates.

Melanoma Studies

Castle Bioscience:  Development and Validation of a Gene Expression Assay to Predict the Risk of Metastatic Disease in Malignant Cutaneous Melanoma  

Amgen 20110266: A Phase 2, Multicenter, Randomized, Open-label Trial Assessing the Efficacy and Safety of  Talimogene Laherparepvec Neoadjuvant Treatment Plus Surgery Versus Surgery Alone for Resectable, Stage IIIB  to IVM1a Melanoma

Amgen 20120166: A Phase 3b, Multicenter, Open-label, Single-arm, Expanded Access Protocol of Talimogene Laherparepvec  for the Treatment of Subjects With Unresected,Stage lllB to IVM1c Melanoma (coming soon)

Amgen 20120139:    "A Registry Study to Evaluate the Survival and Long-Term Safety of Subjects with Melanoma Who Previously Received Talimogene Laherparepvec."  (coming soon)

Glioblastoma Studies

A221101 “A Phase III Randomized, Double-Blind Placebo Controlled Study of Armodfinil (Nuvigil) To Reduce Cancer-Related Fatigue in Patients with Glioblastoma